中国医学创新
中國醫學創新
중국의학창신
Medical Innovation of China
2015年
28期
40-42
,共3页
连续肾脏替代治疗%间歇肾脏替代治疗%急性肾衰竭%疗效
連續腎髒替代治療%間歇腎髒替代治療%急性腎衰竭%療效
련속신장체대치료%간헐신장체대치료%급성신쇠갈%료효
Continuous renal replacement%Intermittent renal replacement%Acute renal failure%Curative effect
目的：观察连续肾脏替代治疗在重症患者急性肾衰竭时的临床疗效。方法：选择2012年1月-2014年6月在本院进行ARF治疗的患者共计56例，分为对照组及治疗组各28例，治疗组采用连续肾脏替代治疗方案，对照组采用间歇肾脏替代治疗方案，4周后观察两组患者观察患者治疗前后BUN、Scr、的实验室指标变化，以及患者并发症发生情况、患者的存活率。结果：4周后，治疗组与对照组BUN、Scr均较治疗前明显下降，且治疗组下降更明显，比较差异具有统计学意义（P<0.05）。治疗组共计发生5例并发症，发生率为17.86%，对照组15例，发生率为53.57%，治疗组并发症发生率明显低于对照组，比较差异有统计学意义（P<0.05）。治疗组死亡4例，病死率为14.29%，对照组死亡12例，病死率为42.86%，治疗组的病死率明显低于对照组，比较差异具有统计学意义（P<0.05）。结论：连续肾脏替代治疗在重症患者急性肾衰竭时的疗效可靠，值得临床推广。
目的：觀察連續腎髒替代治療在重癥患者急性腎衰竭時的臨床療效。方法：選擇2012年1月-2014年6月在本院進行ARF治療的患者共計56例，分為對照組及治療組各28例，治療組採用連續腎髒替代治療方案，對照組採用間歇腎髒替代治療方案，4週後觀察兩組患者觀察患者治療前後BUN、Scr、的實驗室指標變化，以及患者併髮癥髮生情況、患者的存活率。結果：4週後，治療組與對照組BUN、Scr均較治療前明顯下降，且治療組下降更明顯，比較差異具有統計學意義（P<0.05）。治療組共計髮生5例併髮癥，髮生率為17.86%，對照組15例，髮生率為53.57%，治療組併髮癥髮生率明顯低于對照組，比較差異有統計學意義（P<0.05）。治療組死亡4例，病死率為14.29%，對照組死亡12例，病死率為42.86%，治療組的病死率明顯低于對照組，比較差異具有統計學意義（P<0.05）。結論：連續腎髒替代治療在重癥患者急性腎衰竭時的療效可靠，值得臨床推廣。
목적：관찰련속신장체대치료재중증환자급성신쇠갈시적림상료효。방법：선택2012년1월-2014년6월재본원진행ARF치료적환자공계56례，분위대조조급치료조각28례，치료조채용련속신장체대치료방안，대조조채용간헐신장체대치료방안，4주후관찰량조환자관찰환자치료전후BUN、Scr、적실험실지표변화，이급환자병발증발생정황、환자적존활솔。결과：4주후，치료조여대조조BUN、Scr균교치료전명현하강，차치료조하강경명현，비교차이구유통계학의의（P<0.05）。치료조공계발생5례병발증，발생솔위17.86%，대조조15례，발생솔위53.57%，치료조병발증발생솔명현저우대조조，비교차이유통계학의의（P<0.05）。치료조사망4례，병사솔위14.29%，대조조사망12례，병사솔위42.86%，치료조적병사솔명현저우대조조，비교차이구유통계학의의（P<0.05）。결론：련속신장체대치료재중증환자급성신쇠갈시적료효가고，치득림상추엄。
Objective:To observe the clinical effect of continuous renal replacement therapy on treating acute renal failure of severe patients. Method:56 patients achieved ARF treatment in our hospital from January 2012 to June 2014 were selected,they were divided into control group and treatment group,28 cases in each group,the treatment group was treated with continuous renal replacement scheme,and the control group used intermittent renal replacement therapy program,to observe BUN,Scr,changes of laboratory index,survival rate and occurrence of complications before treatment and after 4 weeks of treatment of the two groups. Result:After 4 weeks ,BUN,Scr of the two groups significantly decreased than before treatment,and the treatment group was more obvious than the control group,with statistical significance(P<0.05). There were 5 patients occurred complications in the treatment group,the incidence rate was 17.86%,and there were 15 cases in the control group,the incidence was 53.57%. Treatment group’s incidence was significantly lower than that of the control group,with statistical significance(P<0.05). There were 4 cases died in the treatment group,the mortality rate was 14.29%,12 cases died in the control group,the fatality rate was 42.86%, mortality rates of treatment group was significantly lower than that of the control group,with statistical difference(P<0.05). Conclusion:The effect of continuous renal replacement therapy is reliable on treatment of acute renal failure,it is worth the clinical promotion.
